Zura Bio Limited
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +200.0% | +66.7% | +80.0% | +22.2% | +27.3% | +7.1% | +6.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -98.9% | +388.2% | +5,487.7% | -78.9% | +478.0% | -86.0% | +74.5% | -48.1% | +54.2% | +8.8% | +53.3% | +13.4% | -16.9% | +37.3% | -8.3% | +34.6% | +40.4% | – | |
| – | – | – | – | – | – | -22.4% | +139.8% | +81.1% | +100.2% | +9.6% | -37.2% | +22.5% | +30.0% | +113.7% | -51.2% | +35.2% | +6.6% | -19.1% | -1.5% | +44.2% | -19.9% | – | |
| – | -91.9% | +1,581.5% | +59.9% | -19.9% | +124.8% | +15.2% | +2,217.9% | -68.8% | +339.2% | -70.0% | +6.3% | -22.6% | +40.3% | +64.3% | -18.6% | +22.4% | -6.2% | +8.1% | -5.7% | +38.5% | +15.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -101.0% | – | -85.9% | -81.9% | -725.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -298.8% | – | – | – | -4.2% | – | – | – | – | +1,337.5% | – | – | – | |
| – | -101.0% | – | -85.9% | -81.9% | -725.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -101.0% | – | -85.9% | -81.9% | -725.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.